Tech Company Financing Transactions
Inato Funding Round
Inato secured a $20 million Series A funding round on 3/28/2023. Backers included Cathay Innovation, La Maison and Obvious Ventures.
Transaction Overview
Company Name
Announced On
3/28/2023
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Proceeds Purpose
The company intends to use the new funding for continued product innovation, international growth, and hiring of talent. Inato will advance its diversity product offering to enable sponsors to strategically meet their diversity goals based on new FDA requirements, invest in oncology-specific innovation, further define and scale its data model to continue to improve matching reliability between community sites and sponsor trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
800 Village Walk 198
Guilford, CT 06437
USA
Guilford, CT 06437
USA
Phone
Undisclosed
Website
Email Address
Overview
At Inato, our mission is to bring clinical research to each and every patient, regardless of who they are and where they live. We envision a world where participating in a trial is so simple that all doctors can offer the right trial for their patients. By enabling all community sites to offer the right trials to their patients, we will not only make clinical research more inclusive, but also more efficient.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 3/28/2023: Sirius Medical venture capital transaction
Next: 3/28/2023: EigenLayer venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs